当前位置: 首页 >> 检索结果
共有 457 条符合本次的查询结果, 用时 4.1534842 秒

421. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review.

作者: Zhen Wang.;Jun-Qiang Chen.
来源: BMC Gastroenterol. 2011年11卷19页
Hepatic and peritoneal metastases of gastric cancer are operation contraindications. Systematic review to provide an overview of imaging in predicting the status of liver and peritoneum pre-therapeutically is essential.

422. Helicobacter pylori infection and circulating ghrelin levels - a systematic review.

作者: Chidi V Nweneka.;Andrew M Prentice.
来源: BMC Gastroenterol. 2011年11卷7页
The nature of the association between ghrelin, an orexigenic hormone produced mainly in the stomach, and Helicobacter pylori (H pylori), a bacterium that colonises the stomach, is still controversial. We examined available evidence to determine whether an association exists between the two; and if one exists, in what direction.

423. Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis.

作者: Zhong-Hua Lin.;Yong-Ning Xin.;Quan-Jiang Dong.;Qing Wang.;Xiang-Jun Jiang.;Shu-Hui Zhan.;Ying Sun.;Shi-Ying Xuan.
来源: BMC Gastroenterol. 2010年10卷145页
HLA-DRB1 allele polymorphisms have been reported to be associated with hepatocellular carcinoma susceptibility, but the results of these previous studies have been inconsistent. The purpose of the present study was to explore whether specific HLA-DRB1 alleles (DRB1*07, DRB1*12, DRB1*15) confer susceptibility to hepatocellular carcinoma.

424. Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy.

作者: Devidas Menon.;Tania Stafinski.;Heng Wu.;Darren Lau.;Clarence Wong.
来源: BMC Gastroenterol. 2010年10卷111页
Recently, several new endoscopic treatments have been used to treat patients with Barrett's esophagus with high grade dysplasia. This systematic review aimed to determine the safety and effectiveness of these treatments compared with esophagectomy.

425. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma.

作者: Yanming Zhou.;Yanfang Zhao.;Bin Li.;Donghui Xu.;Zhengfeng Yin.;Feng Xie.;Jiamei Yang.
来源: BMC Gastroenterol. 2010年10卷78页
There is no clear consensus on the better therapy [radiofrequency ablation (RFA) versus hepatic resection (HR)] for small hepatocellular carcinoma (HCC) eligible for surgical treatments. This study is a meta-analysis of the available evidence.

426. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

作者: Gloria Woo.;George Tomlinson.;Yasunori Nishikawa.;Matthew Kowgier.;Morris Sherman.;David K H Wong.;Ba Pham.;Wendy J Ungar.;Thomas R Einarson.;E Jenny Heathcote.;Murray Krahn.
来源: Gastroenterology. 2010年139卷4期1218-29页
The relative efficacies of licensed antiviral therapies for treatment-naive chronic hepatitis B (CHB) infection in randomized controlled trials have not been determined. We evaluated the relative efficacies of the first 12 months of CHB treatments.

427. Moxibustion for ulcerative colitis: a systematic review and meta-analysis.

作者: Dong-Hyo Lee.;Jong-In Kim.;Myeong Soo Lee.;Tae-Young Choi.;Sun-Mi Choi.;Edzard Ernst.
来源: BMC Gastroenterol. 2010年10卷36页
Complementary and alternative medicine (CAM) is increasingly used for treatment of inflammatory bowel disease (IBD). Acupuncture-type treatments are among the most popular options. Several studies have reported that moxibustion is effective in ulcerative colitis (UC). The objective of this review was to assess the clinical evidence for or against moxibustion as a treatment for UC.

428. Plastic or metal stents for benign extrahepatic biliary strictures: a systematic review.

作者: Petra G A van Boeckel.;Frank P Vleggaar.;Peter D Siersema.
来源: BMC Gastroenterol. 2009年9卷96页
Benign biliary strictures may be a consequence of surgical procedures, chronic pancreatitis or iatrogenic injuries to the ampulla. Stents are increasingly being used for this indication, however it is not completely clear which stent type should be preferred.

429. Manganese in parenteral nutrition: who, when, and why should we supplement?

作者: Gil Hardy.
来源: Gastroenterology. 2009年137卷5 Suppl期S29-35页
Micronutrient requirements are not fully understood. Parenteral nutrition (PN) usually contains the trace element (TE) manganese (Mn) from fixed-concentration TE supplements. Multiple TE formulations may not be optimal in pediatric and home PN. Moreover, most PN products contain Mn as a ubiquitous contaminant. Excessive Mn can lead to Parkinson-like symptoms resulting from hypermanganesemia. A survey of 40 Australasian hospitals that contributed data on 108 patients to the annual home PN register and a systematic review of the literature were conducted to establish the scope of the potential problem of Mn toxicity in PN patients. Exposure to Mn doses 5-6 times current daily requirements, together with the TE contamination that is reported in PN products, can lead to neurotoxicity. Whole-blood levels are more accurate for monitoring and correlate well with signal intensity of magnetic resonance imaging. Current TE formulations restrict prescribing options. The regulatory mechanisms of Mn homeostasis are bypassed via the parenteral route so elimination via the hepatobiliary system is impaired, resulting in tissue or brain accumulation. Published dosage recommendations may be excessive and official guidelines require revision. Variability in clinical practices necessitates that individual TE additives are more widely available and multiple TE products reformulated. More frequent monitoring for any brain accumulation is recommended. The scarcity of PN-associated Mn deficiency, plus the growing evidence for Mn toxicity, leads to the conclusion that it is unnecessary for Mn to be prescribed routinely for pediatric or long-term PN patients.

430. Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology.

作者: Norberto C Chavez-Tapia.;Felix I Tellez-Avila.;Giorgio Bedogni.;Lory S Crocè.;Flora Masutti.;Claudio Tiribelli.
来源: BMC Gastroenterol. 2009年9卷75页
The cannabinoid-1 receptor blockers have been proposed in the management of obesity and obesity-related liver diseases (fatty liver as NAFLD or NASH). Due to increasing number of patients to be potentially treated and the need to assess the advantage of this treatment in terms of risk/benefit, we analyze the side events reported during the treatment with rimonabant by a systematic review and meta-analysis of all randomized controlled studies.

431. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use.

作者: Sebastian Straube.;Martin R Tramèr.;R Andrew Moore.;Sheena Derry.;Henry J McQuay.
来源: BMC Gastroenterol. 2009年9卷41页
Some people who suffer an upper gastrointestinal bleed or perforation die. The mortality rate was estimated at 12% in studies published before 1997, but a systematic survey of more recent data is needed. Better treatment is likely to have reduced mortality. An estimate of mortality is helpful in explaining to patients the risks of therapy, especially with NSAIDs.

432. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.

作者: Carmen Bouza.;Teresa López-Cuadrado.;Raimundo Alcázar.;Zuleika Saz-Parkinson.;José María Amate.
来源: BMC Gastroenterol. 2009年9卷31页
Percutaneous radiofrequency ablation (RFA) has gained popularity in the treatment of hepatocellular carcinoma (HCC). However, its role versus other conventional minimally invasive therapies is still a matter of debate. The purpose of this work is to analyse the efficacy and safety of RFA versus that of ethanol injection (PEI), the percutaneous standard approach to treat nonsurgical HCC.

433. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome.

作者: Nourieh Hoveyda.;Carl Heneghan.;Kamal R Mahtani.;Rafael Perera.;Nia Roberts.;Paul Glasziou.
来源: BMC Gastroenterol. 2009年9卷15页
Irritable Bowel Syndrome (IBS) is a common chronic gastrointestinal disorder and the evidence for efficacy of most drug therapies in the treatment of IBS is weak. A popular alternative is probiotics, which have been used in several conditions. including IBS. Probiotics are live microbial food supplements.The aim of this systematic review and meta-analysis of randomized trials study was to evaluate the efficacy of probiotics in alleviating symptoms in patients with irritable bowel syndrome. We searched Ovid versions of MEDLINE (1950-2007), EMBASE (1980-2007), CINAHL (1982-2007), AMED (1985-2007), the Cochrane library and hand searched retrieved papers.

434. Symptoms of gastroesophageal reflux disease in severely mentally retarded people: a systematic review.

作者: Anke J E de Veer.;Judith T Bos.;Riet C Niezen-de Boer.;Clarisse J M Böhmer.;Anneke L Francke.
来源: BMC Gastroenterol. 2008年8卷23页
Gastroesophageal reflux disease (GERD) occurs when stomach acid frequently backs up (or refluxes) into the gullet (or esophagus), and it has serious consequences for the quality of life. Usually this is felt as heartburn. Because severely mentally retarded people usually do not utter complaints of heartburn, it requires a high index of suspicion to discover possible GERD. Therefore it is relevant for care professionals such as nurses to have knowledge of those with a higher risk of GERD and of the possible manifestations of GERD.

435. Epidemiology of constipation in Europe and Oceania: a systematic review.

作者: George Peppas.;Vangelis G Alexiou.;Eleni Mourtzoukou.;Matthew E Falagas.
来源: BMC Gastroenterol. 2008年8卷5页
We aimed to review the literature regarding the epidemiology of constipation in Europe and Oceania and the associated prevalence/risk factors.

436. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

作者: Glenn T Furuta.;Chris A Liacouras.;Margaret H Collins.;Sandeep K Gupta.;Chris Justinich.;Phil E Putnam.;Peter Bonis.;Eric Hassall.;Alex Straumann.;Marc E Rothenberg.; .
来源: Gastroenterology. 2007年133卷4期1342-63页
During the last decade, clinical practice saw a rapid increase of patients with esophageal eosinophilia who were thought to have gastroesophageal reflux disease (GERD) but who did not respond to medical and/or surgical GERD management. Subsequent studies demonstrated that these patients had a "new" disease termed eosinophilic esophagitis (EE). As recognition of EE grew, so did confusion surrounding diagnostic criteria and treatment. To address these issues, a multidisciplinary task force of 31 physicians assembled with the goal of determining diagnostic criteria and making recommendations for evaluation and treatment of children and adults with suspected EE. Consensus recommendations were based upon a systematic review of the literature and expert opinion. EE is a clinicopathological disease characterized by (1) Symptoms including but not restricted to food impaction and dysphagia in adults, and feeding intolerance and GERD symptoms in children; (2) > or = 15 eosinophils/HPF; (3) Exclusion of other disorders associated with similar clinical, histological, or endoscopic features, especially GERD. (Use of high dose proton pump inhibitor treatment or normal pH monitoring). Appropriate treatments include dietary approaches based upon eliminating exposure to food allergens, or topical corticosteroids. Since EE is a relatively new disease, the intent of this report is to provide current recommendations for care of affected patients and defining gaps in knowledge for future research studies.

437. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review.

作者: Suzanne M Jeurnink.;Casper H J van Eijck.;Ewout W Steyerberg.;Ernst J Kuipers.;Peter D Siersema.
来源: BMC Gastroenterol. 2007年7卷18页
Gastrojejunostomy (GJJ) is the most commonly used palliative treatment modality for malignant gastric outlet obstruction. Recently, stent placement has been introduced as an alternative treatment. We reviewed the available literature on stent placement and GJJ for gastric outlet obstruction, with regard to medical effects and costs.

438. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.

作者: Chinyu Su.;James D Lewis.;Brittany Goldberg.;Colleen Brensinger.;Gary R Lichtenstein.
来源: Gastroenterology. 2007年132卷2期516-26页
Knowledge of the placebo outcomes and understanding specific study features that influence these outcomes is important for designing future clinical trials evaluating therapy of ulcerative colitis (UC). The aims of this study were to estimate the placebo rates of remission and response in placebo-controlled, randomized clinical trials for active UC and to identify factors influencing these rates.

439. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review.

作者: Gennaro D'Amico.;Juan Carlos Garcia-Pagan.;Angelo Luca.;Jaime Bosch.
来源: Gastroenterology. 2006年131卷5期1611-24页
A reduction of the hepatic venous pressure gradient (HVPG) to </=12 mm Hg or by >/=20% of baseline prevents variceal bleeding in cirrhosis. Because some inconsistent data have argued against the clinical application of these hemodynamic targets, we performed a systematic review of available studies from the Cochrane Library and MEDLINE.

440. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis.

作者: Susanna C Larsson.;Edward Giovannucci.;Alicja Wolk.
来源: Gastroenterology. 2006年131卷4期1271-83页
Increasing evidence suggests that a low folate intake and impaired folate metabolism may be implicated in the development of gastrointestinal cancers. We conducted a systematic review with meta-analysis of epidemiologic studies evaluating the association of folate intake or genetic polymorphisms in 5,10-methylenetetrahydrofolate reductase (MTHFR), a central enzyme in folate metabolism, with risk of esophageal, gastric, or pancreatic cancer.
共有 457 条符合本次的查询结果, 用时 4.1534842 秒